Article Versions Notes

Wetz C, Ruhwedel T, Schatka I, Grabowski J, Jann H, Metzger G, Galler M, Amthauer H, Rogasch JMM. Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy. Cancers. 2023; 15(24):5717. https://doi.org/10.3390/cancers15245717

Wetz, Christoph, Tristan Ruhwedel, Imke Schatka, Jane Grabowski, Henning Jann, Giulia Metzger, Markus Galler, Holger Amthauer, and Julian M. M. Rogasch. 2023. "Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy" Cancers 15, no. 24: 5717. https://doi.org/10.3390/cancers15245717

Wetz, C., Ruhwedel, T., Schatka, I., Grabowski, J., Jann, H., Metzger, G., Galler, M., Amthauer, H., & Rogasch, J. M. M. (2023). Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy. Cancers, 15(24), 5717. https://doi.org/10.3390/cancers15245717